Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_assertion type Assertion NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_head.
- NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_assertion description "[Strong clinical evidence shows that gliomas with methylation and subsequent silencing of the MGMT promoter are sensitive to temozolomide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_provenance.
- NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_assertion evidence source_evidence_literature NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_provenance.
- NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_assertion SIO_000772 18089777 NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_provenance.
- NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_assertion wasDerivedFrom befree-2016 NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_provenance.
- NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_assertion wasGeneratedBy ECO_0000203 NP645914.RA7nYkGxYIlfJ-reoCynv16F0NdxWarT2YFaaYgxN9pcY130_provenance.